Arkolith/Insider Trading/ANTX/Form 4

Prior Stephen David

Chief Strategy OfficerAN2 Therapeutics, Inc. (ANTX) · full profile →Form 4 · filed Nov 6, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$872
Net Open-Market Flow
-$872
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 4, 2025Sell(S)765$1.14$87266K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-270252) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML